Company Overview

Development Stage

About the Company

[Summary] 以文化人、天长地久。

浙江英特集团股份有限公司(以下简称“英特集团”、“公司”)是浙江省国资委控股的浙江省国际贸易集团旗下的上市公司,前身为“凯地丝绸”,股票代码为SZ.000411。
2001年12月,公司通过资产重组控股浙江英特药业有限责任公司(简称“英特药业”),公司主营业务转型为医药流通,并更名为浙江英特集团股份有限公司。英特药业的前身是成立于1950年7月的浙江人民医药公司;1998年,浙江省医药药材有限公司、浙江省医药工业公司、浙江省医药器械公司、浙江省医药科技公司四家公司进行战略重组,合并成立英特药业。2008年,中国中化集团入主控股英特集团。2017年,英特集团重回浙江省国际贸易集团控股管理。
公司为区域性医药流通龙头企业,以经营药品、中药、生物器械为主营业务,以医药专业分销、现代物流、电子商务、生产加工及终端零售为主要经营业态,下属包括浙江英特药业有限责任公司、浙江英特医药药材有限公司、浙江省医疗器械有限公司等三十余家成员企业,销售网络遍布浙江、辐射华东。公司2017年度营业收入189.07亿元,2017年末总资产90.83亿元、所有者权益19.05亿元。公司连续多年荣获“中国服务企业500强”、“中国医药流通百强企业”、“中国医药行业电子商务龙头企业“、“浙江省百强企业”、“浙江省重点流通企业”、“浙江省省级医药重点储备单位”等荣誉称号,是中国医药商业协会、浙江医药行业协会副会长单位。
公司以成为“中国*优秀的医药健康综合服务商”为愿景,围绕“外延式扩张、内涵式增长、整合式提升、创新式发展、生态圈协同”的战略路径,巩固提升药品分销核心业务,加快发展中药和保健品、生物制品、医疗器械、智慧物流、信息经济、新型医药零售等战略业务,致力于将公司打造成为一个主业鲜明、经营特色、管理先进的大型现代化医药健康产业集团。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

浙江英特集团股份有限公司 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market:
  • Deal:

浙江英特集团股份有限公司 How Fast Is Hiring Growing? (7 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 27%
  • 2024: Down 27%
  • 2023: Up 232%
  • 2022: Down 72%
浙江英特集团股份有限公司 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 浙江英特药业有限责任公司 growing? 浙江英特集团股份有限公司2025: 145 openings (up 27%), 2024: 114 openings (down 27%), 2023: 156 openings (up 232%), 2022: 47 openings (down 72%), 2021: 166 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

浙江英特集团股份有限公司 Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
浙江英特集团股份有限公司 Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 浙江英特药业有限责任公司 growing? 浙江英特集团股份有限公司Master's recruitment over the years: 2026: 4 openings (down 37%), 2024: 4 openings (down 27%), 2023: 3 openings (up 232%), 2021: 4 openings.

浙江英特集团股份有限公司 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 浙江英特药业有限责任公司? Based on an analysis of 浙江英特集团股份有限公司's job postings over the past year, "医疗卫生/美容保健类" demand: 32.1%, "计算机/网络/技术类": 4.4%. For reference only.

浙江英特集团股份有限公司 — What Are the Salaries Like? (137 records)

Manage
浙江英特集团股份有限公司 Salary Overview
salary range: 2K - 50K, 78.1% of roles pay ¥4.5-15K
Note: salary statistics are based on 137 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 浙江英特药业有限责任公司?浙江英特集团股份有限公司78.1% of positions earn 4.5-15K, Undergraduate salary: ¥。医疗卫生/美容保健类 average salary ¥8.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 浙江英特集团股份有限公司

(More)
Are salaries high at 浙江英特药业有限责任公司? We provide: 实习生,医药代表,销售,药师,运营,财务,药店,人力,信息,药剂,营业员,调剂员,质量,采购,中药调剂,外派员,店长,操作工,普工,管培生. Click to view detailed salary analysis by job.

浙江英特集团股份有限公司 honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

浙江英特集团股份有限公司 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 医疗卫生/美容保健类
    31.9% of total 31.9%
  • 销售类
    30.4% of total 30.4%
  • 在校学生类
    15.2% of total 15.2%
  • 质量管理类
    10.9% of total 10.9%

Education

  • 大专
    44.9% of total 44.9%
  • 本科
    39.1% of total 39.1%
  • 不限
    6.5% of total 6.5%
  • 高中
    4.3% of total 4.3%

Experience

  • 不限
    68.1% of total 68.1%
  • 1-3年
    16.7% of total 16.7%
  • 3-5年
    13% of total 13%
  • 5-10年
    2.2% of total 2.2%
View Detailed Analysis

What does 浙江英特药业有限责任公司 require? Who is 浙江英特集团股份有限公司 hiring? 浙江英特集团股份有限公司 recruitment: 医疗卫生/美容保健类占比最多占31.9%,其次是销售类占30.4%. What education can get in at 浙江英特集团股份有限公司? 大专占比最多占44.9%,其次是本科占39.1%. High education required at 浙江英特集团股份有限公司? 硕士占2.9%. Work experience required at 浙江英特集团股份有限公司? 不限占比最多占68.1%,其次是1-3年占16.7%. Where are the job locations at 浙江英特集团股份有限公司? 杭州占比最多占50%,其次是宁波占16.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 42,600万(元)
Legal Representative: 刘琼
Date Established:
Credit Code: 91330000710959638J
Registered Address: 浙江省杭州市拱墅区上塘街道臻创巷198号12层、13层1301-1317室

Partners & Suppliers

浙江高跖医药科技股份有限公司与浙江英特药业有限责任公司签订药品分销协议,通过其渠道销售产品。 Source
供应商 医药商业/分销
向瑞人堂供应处方药品 Source
合作客户 处方药
福元药业通过浙江英特分销药品 Source
供应商 医药商业
药品经销合作,永宁药业通过浙江英特销售其药品 Source
供应商 药品流通
浙江杭康药业有限公司向浙江英特药业有限责任公司销售药品,英特药业为其区域经销商。 Source
供应商 医药商业/分销

People who follow 浙江英特集团股份有限公司 also follow

浙江英特集团股份有限公司 Competitors (Similar Companies)

“以文化人、天长地久。”
“Mainly engaged in the production and sales of antibiotics, traditional”
“Mainly engaged in the production and sales of antibiotics, traditional”
药品零售 连锁 销售 医保定点
“A provincial high-tech enterprise specializing in the development, pro”
“Gathering global wisdom, creating grand endeavors, dedicating utmost s”
“To produce more affordable and effective medicines for the Chinese peo”
“A landmark enterprise in the modernization of traditional Chinese medi”
“光大百年品牌,成为受用户信任的传统名药制造商”
研究院/研究所 创新药 药物研发 医药
“Professional services for the entire clinical trial process of drug pr”
“Products for the diagnosis and treatment of allergic diseases”
药品零售 零售 医保定点 药房/药店
“主营医药中间体、原料药和成品药的研发、生产与销售”
物业 公寓管理 保洁 后勤服务

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates